Maravai Lifesciences Holdings Stock Gross Profit
| MRVI Stock | USD 3.07 0.16 4.95% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Maravai Lifesciences' long-term financial health and intrinsic value.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Maravai Lifesciences Holdings Company Gross Profit Analysis
Maravai Lifesciences' Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Current Maravai Lifesciences Gross Profit | 67.12 M |
Most of Maravai Lifesciences' fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Maravai Lifesciences Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
| Competition |
According to the company disclosure, Maravai Lifesciences Holdings reported 67.12 M of gross profit. This is 97.01% lower than that of the Life Sciences Tools & Services sector and 92.94% lower than that of the Health Care industry. The gross profit for all United States stocks is 99.75% higher than that of the company.
Maravai Gross Profit Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Maravai Lifesciences' direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Maravai Lifesciences could also be used in its relative valuation, which is a method of valuing Maravai Lifesciences by comparing valuation metrics of similar companies.Maravai Lifesciences is currently under evaluation in gross profit category among its peers.
Maravai Fundamentals
| Return On Equity | -0.55 | ||||
| Return On Asset | -0.0589 | ||||
| Profit Margin | (0.88) % | ||||
| Operating Margin | (0.75) % | ||||
| Current Valuation | 523.37 M | ||||
| Shares Outstanding | 144.68 M | ||||
| Shares Owned By Insiders | 10.16 % | ||||
| Shares Owned By Institutions | 89.88 % | ||||
| Number Of Shares Shorted | 13.43 M | ||||
| Price To Earning | 7.79 X | ||||
| Price To Book | 1.62 X | ||||
| Price To Sales | 5.56 X | ||||
| Revenue | 259.19 M | ||||
| Gross Profit | 67.12 M | ||||
| EBITDA | (156.92 M) | ||||
| Net Income | (259.62 M) | ||||
| Cash And Equivalents | 617.45 M | ||||
| Cash Per Share | 4.69 X | ||||
| Total Debt | 376.69 M | ||||
| Debt To Equity | 0.69 % | ||||
| Current Ratio | 7.22 X | ||||
| Book Value Per Share | 1.84 X | ||||
| Cash Flow From Operations | 7.46 M | ||||
| Short Ratio | 7.98 X | ||||
| Earnings Per Share | (1.37) X | ||||
| Price To Earnings To Growth | (0.22) X | ||||
| Target Price | 4.0 | ||||
| Number Of Employees | 560 | ||||
| Beta | 0.33 | ||||
| Market Capitalization | 1.22 B | ||||
| Total Asset | 1.01 B | ||||
| Retained Earnings | 140.89 M | ||||
| Working Capital | 372.18 M | ||||
| Net Asset | 1.01 B |
About Maravai Lifesciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Maravai Lifesciences Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Maravai Lifesciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Maravai Lifesciences Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| VOO | Vanguard SP 500 | |
| XLK | Technology Select Sector | |
| XLV | Health Care Select | |
| QQQ | Invesco QQQ Trust | |
| XLC | Communication Services Select |
Check out Maravai Lifesciences Piotroski F Score and Maravai Lifesciences Altman Z Score analysis. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Maravai Lifesciences. If investors know Maravai will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Maravai Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Maravai Lifesciences is measured differently than its book value, which is the value of Maravai that is recorded on the company's balance sheet. Investors also form their own opinion of Maravai Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Maravai Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Maravai Lifesciences' market value can be influenced by many factors that don't directly affect Maravai Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Maravai Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Maravai Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Maravai Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.